Pfizer COVID-19 Vaccine Was Just 12% Effective Against Omicron in Kids Ages 5 to 11, Study Finds
Pfizer and BioNTech’s two-dose COVID-19 vaccine provided very little protection for children aged 5 to 11 during the wave of omicron infection in New York,